Sun Pharma proclaims USFDA approval for Generic Lenalidomide Capsules

Sun Pharma proclaims USFDA approval for Generic Lenalidomide Capsules

by admin- Friday, February 10th, 2023 04:02:43 PM

Sun Pharmaceutical Industries introduced that one in all its completely owned subsidiaries has received final approval from USFDA for its Abbreviated New Drug Application (ANDA) for common lenalidomide Capsules, 5mg, 10mg, 15mg, 25mg and tentative acclaim for 2.5mg, 20mg. The respective product
approval is primarily based on Revlimid® Capsules, 5mg, 10mg, 15mg, 25mg and a pair of.5mg, 20mg as a reference product.

News Updates